Logo image of PHLT

PERFORMANT HEALTHCARE INC (PHLT) Stock Fundamental Analysis

NASDAQ:PHLT - Nasdaq - US71377E1055 - Common Stock - Currency: USD

2.6  -0.01 (-0.38%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PHLT. PHLT was compared to 102 industry peers in the Health Care Providers & Services industry. PHLT has a great financial health rating, but its profitability evaluates not so good. PHLT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PHLT had negative earnings in the past year.
In the past year PHLT had a positive cash flow from operations.
In the past 5 years PHLT always reported negative net income.
PHLT had a positive operating cash flow in 4 of the past 5 years.
PHLT Yearly Net Income VS EBIT VS OCF VS FCFPHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

PHLT has a Return On Assets of -5.66%. This is in the lower half of the industry: PHLT underperforms 68.63% of its industry peers.
PHLT has a Return On Equity (-7.63%) which is in line with its industry peers.
Industry RankSector Rank
ROA -5.66%
ROE -7.63%
ROIC N/A
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
PHLT Yearly ROA, ROE, ROICPHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

PHLT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHLT Yearly Profit, Operating, Gross MarginsPHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

More info and screens

8

2. Health

2.1 Basic Checks

PHLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
PHLT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PHLT has been increased compared to 5 years ago.
Compared to 1 year ago, PHLT has a worse debt to assets ratio.
PHLT Yearly Shares OutstandingPHLT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PHLT Yearly Total Debt VS Total AssetsPHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

PHLT has an Altman-Z score of 4.86. This indicates that PHLT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.86, PHLT belongs to the top of the industry, outperforming 84.31% of the companies in the same industry.
The Debt to FCF ratio of PHLT is 1.93, which is an excellent value as it means it would take PHLT, only 1.93 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.93, PHLT belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
PHLT has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
PHLT has a better Debt to Equity ratio (0.10) than 74.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.93
Altman-Z 4.86
ROIC/WACCN/A
WACC9.09%
PHLT Yearly LT Debt VS Equity VS FCFPHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

PHLT has a Current Ratio of 2.56. This indicates that PHLT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.56, PHLT belongs to the best of the industry, outperforming 85.29% of the companies in the same industry.
A Quick Ratio of 2.56 indicates that PHLT has no problem at all paying its short term obligations.
PHLT has a better Quick ratio (2.56) than 85.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.56
Quick Ratio 2.56
PHLT Yearly Current Assets VS Current LiabilitesPHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

PHLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.33%, which is quite impressive.
Looking at the last year, PHLT shows a quite strong growth in Revenue. The Revenue has grown by 11.76% in the last year.
The Revenue has been decreasing by -3.95% on average over the past years.
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)11.76%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%21.71%

3.2 Future

The Earnings Per Share is expected to grow by 66.09% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 10.32% on average over the next years. This is quite good.
EPS Next Y89.54%
EPS Next 2Y66.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.41%
Revenue Next 2Y10.32%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHLT Yearly Revenue VS EstimatesPHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
PHLT Yearly EPS VS EstimatesPHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

PHLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 26.37, which means the current valuation is very expensive for PHLT.
The rest of the industry has a similar Price/Forward Earnings ratio as PHLT.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.94, PHLT is valued a bit more expensive.
Industry RankSector Rank
PE N/A
Fwd PE 26.37
PHLT Price Earnings VS Forward Price EarningsPHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PHLT is valued a bit more expensive than the industry average as 64.71% of the companies are valued more cheaply.
PHLT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 49.03
EV/EBITDA 131.18
PHLT Per share dataPHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PHLT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PHLT's earnings are expected to grow with 66.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.09%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PHLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERFORMANT HEALTHCARE INC

NASDAQ:PHLT (5/22/2025, 10:07:29 AM)

2.6

-0.01 (-0.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners80.9%
Inst Owner ChangeN/A
Ins Owners5.34%
Ins Owner Change9.57%
Market Cap203.61M
Analysts82.22
Price Target7.14 (174.62%)
Short Float %1.54%
Short Ratio7.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)107.35%
Min EPS beat(2)41.19%
Max EPS beat(2)173.52%
EPS beat(4)4
Avg EPS beat(4)59.56%
Min EPS beat(4)1.96%
Max EPS beat(4)173.52%
EPS beat(8)7
Avg EPS beat(8)75.85%
EPS beat(12)11
Avg EPS beat(12)65.12%
EPS beat(16)14
Avg EPS beat(16)59.12%
Revenue beat(2)1
Avg Revenue beat(2)4.41%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)9%
Revenue beat(4)2
Avg Revenue beat(4)2.21%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)9%
Revenue beat(8)5
Avg Revenue beat(8)1.59%
Revenue beat(12)7
Avg Revenue beat(12)0.69%
Revenue beat(16)10
Avg Revenue beat(16)2.24%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-39.95%
EPS NQ rev (3m)0%
EPS NY rev (1m)N/A
EPS NY rev (3m)80.01%
Revenue NQ rev (1m)-0.94%
Revenue NQ rev (3m)-2.81%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.37
P/S 1.58
P/FCF 49.03
P/OCF 22.72
P/B 2.61
P/tB 6.62
EV/EBITDA 131.18
EPS(TTM)-0.06
EYN/A
EPS(NY)0.1
Fwd EY3.79%
FCF(TTM)0.05
FCFY2.04%
OCF(TTM)0.11
OCFY4.4%
SpS1.65
BVpS1
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.66%
ROE -7.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 3.22%
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.93
Debt/EBITDA 5.18
Cap/Depr 72.28%
Cap/Sales 3.73%
Interest Coverage N/A
Cash Conversion 580.75%
Profit Quality N/A
Current Ratio 2.56
Quick Ratio 2.56
Altman-Z 4.86
F-Score5
WACC9.09%
ROIC/WACCN/A
Cap/Depr(3y)88.51%
Cap/Depr(5y)80.81%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y89.54%
EPS Next 2Y66.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.76%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%21.71%
Revenue Next Year9.41%
Revenue Next 2Y10.32%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year185.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y199.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2458.16%
OCF growth 3Y88.66%
OCF growth 5YN/A